US Patent Issued to Dizal (Jiangsu) Pharmaceutical on Dec. 23 for "Triazolopyrimidine compounds and their use in treating cancer" (British Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,473, issued on Dec. 23, was assigned to Dizal (Jiangsu) Pharmaceutical Co. Ltd. (Shanghai).

"Triazolopyrimidine compounds and their use in treating cancer" was invented by Frederick Woolf Goldberg (Cambridge, Great Britain), Attilla Kuan Tsuei Ting (Cambridge, Great Britain), Gillian McGregor Lamont (Cambridge, Great Britain), David Buttar (Cambridge, Great Britain) and Jason Grant Kettle (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, X, Ring A, Ring B and Ring C have any of the meanings hereinbefore defined in the...